Furthermore, 8.6% of OSCC primary tumours show an amplification of the YAP1 locus and 21.6% with truncated FAT1 [53], an upstream membrane receptor protein in the Hippo kinase cascade, which results in increased YAP1 activity, malignant progression and poor patient prognosis [54,55]. Here, YAP1 is linked to neoplasm.